{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:35:05Z","timestamp":1789608905385,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI105185"],"award-info":[{"award-number":["R01AI105185"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R01AI163202"],"award-info":[{"award-number":["R01AI163202"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.drup.2024.101156","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:58:29Z","timestamp":1728089909000},"page":"101156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs"],"prefix":"10.1016","volume":"77","author":[{"given":"Derek","family":"Conkle-Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bria M.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nachiket","family":"Thosar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afif","family":"Elghraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faramarz","family":"Valafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2024.101156_bib1","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2023.; 2023."},{"key":"10.1016\/j.drup.2024.101156_bib2","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2020.; 2020a."},{"key":"10.1016\/j.drup.2024.101156_bib3","unstructured":"Walsh S. US-FDA News Release.; 2012."},{"key":"10.1016\/j.drup.2024.101156_bib4","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO). WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment: Annexes 3-9.; 2019. doi:WHO\/CDS\/TB\/2019.3.","DOI":"10.4103\/ijmr.IJMR_579_19"},{"key":"10.1016\/j.drup.2024.101156_bib5","first-page":"677","article-title":"Profile of delamanid for the treatment of multidrug-resistant tuberculosis","volume":"9","author":"Szumowsk","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkaa136","article-title":"Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","volume":"75","author":"Kadura","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.drup.2024.101156_bib7","first-page":"6","article-title":"\u201cB 663\u201d in the treatment of leprosy. Preliminary report of a pilot trial","volume":"33","author":"BROWNE","year":"1962","journal-title":"Lepr. Rev."},{"issue":"20","key":"10.1016\/j.drup.2024.101156_bib8","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMc1505196","article-title":"Acquired resistance to bedaquiline and delamanid in therapy for tuberculosis","volume":"373","author":"Bloemberg","year":"2015","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1164\/rccm.201502-0372LE","article-title":"Delamanid and bedaquiline resistance in mycobacterium tuberculosis ancestral beijing genotype causing extensively drug-resistant tuberculosis in a Tibetan Refugee","volume":"193","author":"Hoffmann","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"5","key":"10.1016\/j.drup.2024.101156_bib10","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of mmpl5 in mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"16","key":"10.1016\/j.drup.2024.101156_bib11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1056\/NEJMoa1201964","article-title":"Linezolid for treatment of chronic extensively drug-resistant tuberculosis","volume":"367","author":"Lee","year":"2012","journal-title":"N. Engl. J. Med"},{"issue":"11","key":"10.1016\/j.drup.2024.101156_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01304-20","article-title":"Characterization of genomic variants associated with resistance to bedaquiline and delamanid in na\u00efve Mycobacterium tuberculosis clinical strains.","volume":"58","author":"Battaglia","year":"2020","journal-title":"J. Clin. Microbiol"},{"issue":"7","key":"10.1016\/j.drup.2024.101156_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00165-18","article-title":"Comparison of In vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant mycobacterium tuberculosis in China","volume":"62","author":"Zong","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ismej.2016.100","article-title":"The methanogenic redox cofactor F420 is widely synthesized by aerobic soil bacteria","volume":"11","author":"Ney","year":"2017","journal-title":"ISME J."},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01948-20","article-title":"Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in mycobacterium tuberculosis","volume":"65","author":"Rifat","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1742-4658.2011.08404.x","article-title":"Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles","volume":"279","author":"Gurumurthy","year":"2012","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.drup.2024.101156_bib19","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/jac\/dkv150","article-title":"Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis","volume":"70","author":"Zhang","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.drup.2024.101156_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00175-0","article-title":"Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis","volume":"2","author":"Ismail","year":"2021","journal-title":"Lancet Microbe"},{"issue":"24","key":"10.1016\/j.drup.2024.101156_bib21","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1128\/JB.183.24.7058-7066.2001","article-title":"Use of transposon Tn5367 mutagenesis and a nitroimidazopyran-based selection system to demonstrate a requirement for fbiA and fbiB in coenzyme F(420) biosynthesis by Mycobacterium bovis BCG","volume":"183","author":"Choi","year":"2001","journal-title":"J. Bacteriol."},{"issue":"6789","key":"10.1016\/j.drup.2024.101156_bib22","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35016103","article-title":"A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis","volume":"405","author":"Stover","year":"2000","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.drup.2024.101156_bib23","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1128\/AAC.00308-15","article-title":"Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis","volume":"59","author":"Haver","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"June 2017)","key":"10.1016\/j.drup.2024.101156_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tube.2017.12.006","article-title":"Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis","volume":"108","author":"Fujiwara","year":"2018","journal-title":"Tuberculosis"},{"issue":"9","key":"10.1016\/j.drup.2024.101156_bib25","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/JB.184.9.2420-2428.2002","article-title":"Demonstration that fbiC is required by Mycobacterium bovis BCG for coenzyme F(420) and FO biosynthesis","volume":"184","author":"Choi","year":"2002","journal-title":"J. Bacteriol."},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib26","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1128\/AAC.00753-16","article-title":"Mutations in pepQ confer low-level resistance to bedaquiline and clofazimine in Mycobacterium tuberculosis","volume":"60","author":"Almeida","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2024.101156_bib27","series-title":"The Lancet Microbe","article-title":"Bedaquiline and clofazimine resistance in <em>Mycobacterium tuberculosis<\/em>: an in-vitro and in-silico data analysis","author":"Sonnenkalb","year":"2023"},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-020-00726-5","article-title":"Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex","volume":"12","author":"Merker","year":"2020","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98862-4","article-title":"Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid","volume":"11","author":"G\u00f3mez-Gonz\u00e1lez","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.drup.2024.101156_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008287","article-title":"Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering","volume":"16","author":"Lee","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drup.2024.101156_bib31","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.dib.2018.09.057","article-title":"Collated data of mutation frequencies and associated genetic variants of bedaquiline, clofazimine and linezolid resistance in Mycobacterium tuberculosis","volume":"20","author":"Ismail","year":"2018","journal-title":"Data Br."},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02530-18","article-title":"High prevalence of bedaquiline resistance in treatment-naive tuberculosis patients and verapamil effectiveness","volume":"63","author":"Ghajavand","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"January 2016","key":"10.1016\/j.drup.2024.101156_bib33","article-title":"Mycobacterium tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid","author":"Zhang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214088","article-title":"Reference set of Mycobacterium tuberculosis clinical strains: A tool for research and product development","volume":"14","author":"Borrell","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2024.101156_bib35","unstructured":"World Health Organization (WHO). The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance.; 2013. doi:WHO\/HTM\/TB\/2013.6."},{"key":"10.1016\/j.drup.2024.101156_bib36","unstructured":"World Health Organization (WHO). Meeting Report of the WHO Expert Consultation on the Definition of Extensively Drug-Resistant Tuberculosis.; 2020b. ISBN 978-92-4-001866-2."},{"key":"10.1016\/j.drup.2024.101156_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2018.04.007","article-title":"Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia","volume":"111","author":"Martinez","year":"2018","journal-title":"Tuberc. (Edinb. )"},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib38","first-page":"684","article-title":"Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline","volume":"72","author":"Villellas","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-020-00726-5","article-title":"Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex","volume":"12","author":"Merker","year":"2020","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.drup.2024.101156_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00239-17","article-title":"Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis","volume":"61","author":"Xu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.drup.2024.101156_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5588\/ijtld.17.0706","article-title":"Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis","volume":"22","author":"Cox","year":"2018","journal-title":"Int J. Tube Lung Dis. J. Int Union Tube Lung Dis."},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13073-020-00817-3","article-title":"Robust barcoding and identification of Mycobacterium tuberculosis lineages for epidemiological and clinical studies","volume":"12","author":"Napier","year":"2020","journal-title":"Genome Med"},{"issue":"4","key":"10.1016\/j.drup.2024.101156_bib43","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.celrep.2013.10.031","article-title":"Genome-wide mapping of transcriptional start sites defines an extensive leaderless transcriptome in mycobacterium tuberculosis","volume":"5","author":"Cortes","year":"2013","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.drup.2024.101156_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005641","article-title":"Leaderless transcripts and small proteins are common features of the mycobacterial translational landscape","volume":"11","author":"Shell","year":"2015","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.drup.2024.101156_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103844","article-title":"Spotlight on alternative frame coding: Two long overlapping genes in Pseudomonas aeruginosa are translated and under purifying selection","volume":"25","author":"Kreitmeier","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.drup.2024.101156_bib46","series-title":"Prepr with Lancet","article-title":"Frameshift mutations in Rv0678 preserve bedaquiline susceptibility in Mycobacterium tuberculosis by maintaining protein integrity","author":"Snobre","year":"2024"},{"issue":"5","key":"10.1016\/j.drup.2024.101156_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2013-14-5-r51","article-title":"Characterizing and measuring bias in sequence data","volume":"14","author":"Ross","year":"2013","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2024.101156_bib48","series-title":"bioRxiv","article-title":"PBHoover and CigarRoller: a method for confident haploid variant calling on Pacific Biosciences data and its application to heterogeneous population analysis","author":"Ramirez-Busby","year":"2018"},{"issue":"9","key":"10.1016\/j.drup.2024.101156_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002946","article-title":"Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis","volume":"8","author":"Zhang","year":"2012","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.drup.2024.101156_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008357","article-title":"Insertion and deletion evolution reflects antibiotics selection pressure in a Mycobacterium tuberculosis outbreak","volume":"16","author":"Godfroid","year":"2020","journal-title":"PLoS Pathog."},{"issue":"16","key":"10.1016\/j.drup.2024.101156_bib51","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1093\/nar\/19.16.4377","article-title":"High-level ribosomal frameshifting directs the synthesis of IS150 gene products","volume":"19","author":"V\u00f6gele","year":"1991","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.drup.2024.101156_bib52","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1073\/pnas.1919390117","article-title":"Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene","volume":"117","author":"Huseby","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib53","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2005-6-3-r25","article-title":"Transcriptional slippage in bacteria: distribution in sequenced genomes and utilization in IS element gene expression","volume":"6","author":"Baranov","year":"2005","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2024.101156_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73980","article-title":"Pervasive translation in Mycobacterium tuberculosis. Kana BD, Shell S, eds","volume":"11","author":"Smith","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.drup.2024.101156_bib55","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.2147\/IDR.S440711","article-title":"Bedaquiline, delamanid, linezolid, clofazimine, and capreomycin MIC distributions for drug resistance mycobacterium tuberculosis in Shanghai, China","volume":"16","author":"Guo","year":"2023","journal-title":"Infect. Drug Resist"},{"issue":"6","key":"10.1016\/j.drup.2024.101156_bib56","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/jac\/dkw044","article-title":"Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC\u2122 MGIT\u2122 960 system.","volume":"71","author":"Schena","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.drup.2024.101156_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106953","article-title":"Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice","volume":"62","author":"Nguyen","year":"2023","journal-title":"Int J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib58","article-title":"associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics","volume":"20","author":"A data compendium","year":"2022","journal-title":"PLoS Biol."},{"issue":"September","key":"10.1016\/j.drup.2024.101156_bib59","article-title":"The TB Portals: An open-access, web-based platform for global drug-resistant tuberculosis data sharing and analysis","author":"Rosenthal","year":"2017","journal-title":"J. Clin. Microbiol"},{"issue":"19","key":"10.1016\/j.drup.2024.101156_bib60","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/bioinformatics\/btw369","article-title":"Assemblytics: a web analytics tool for the detection of variants from an assembly","volume":"32","author":"Nattestad","year":"2016","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib61","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1128\/JCM.42.8.3594-3599.2004","article-title":"Genomic analysis distinguishes Mycobacterium africanum","volume":"42","author":"Mostowy","year":"2004","journal-title":"J. Clin. Microbiol"},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib62","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/gbe\/evy145","article-title":"Unexpected Genomic and Phenotypic Diversity of Mycobacterium africanum Lineage 5 Affects Drug Resistance, Protein Secretion, and Immunogenicity","volume":"10","author":"Ates","year":"2018","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.drup.2024.101156_bib63","article-title":"Hybran: hybrid reference transfer and Ab initio prokaryotic genome annotation","volume":"2022","author":"Elghraoui","year":"2022"},{"key":"10.1016\/j.drup.2024.101156_bib64","series-title":"Nat Methods","article-title":"Accurate detection of complex structural variations using single-molecule sequencing","author":"Sedlazeck","year":"2018"},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.02133-16","article-title":"Comprehensive essentiality analysis of the mycobacterium tuberculosis genome via saturating transposon mutagenesis","volume":"8","author":"DeJesus","year":"2017","journal-title":"MBio"},{"issue":"18","key":"10.1016\/j.drup.2024.101156_bib66","doi-asserted-by":"crossref","first-page":"i333","DOI":"10.1093\/bioinformatics\/bts378","article-title":"DELLY: structural variant discovery by integrated paired-end and split-read analysis","volume":"28","author":"Rausch","year":"2012","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.drup.2024.101156_bib67","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S2666-5247(20)30031-8","article-title":"Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis","volume":"1","author":"Nimmo","year":"2020","journal-title":"Lancet Microbe"},{"issue":"8","key":"10.1016\/j.drup.2024.101156_bib68","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.5588\/ijtld.12.0144","article-title":"O\u2019Donnell MR. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis","volume":"17","author":"Gopal","year":"2013","journal-title":"Int J. Tube Lung Dis."},{"key":"10.1016\/j.drup.2024.101156_bib69","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.drup.2024.101156_bib70","unstructured":"Control of Neglected Tropical Diseases; World Health Organization. Towards Zero Leprosy. Global Leprosy (\u200eHansen\u2019s Disease)\u200e Strategy 2021\u20132030.; 2021. doi:ISBN: 978 92 9022 850 9."},{"key":"10.1016\/j.drup.2024.101156_bib71","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2147\/IDR.S304799","article-title":"Acquired resistance to isoniazid during isoniazid monotherapy in a subject with latent infection following household rifampicin-resistant tuberculosis contact: a case report","volume":"14","author":"Li","year":"2021","journal-title":"Infect. Drug Resist"},{"issue":"2","key":"10.1016\/j.drup.2024.101156_bib72","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1164\/rccm.202011-4239PP","article-title":"Latent tuberculosis: two centuries of confusion","volume":"204","author":"Behr","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.drup.2024.101156_bib73","doi-asserted-by":"crossref","first-page":"l5770","DOI":"10.1136\/bmj.l5770","article-title":"Is Mycobacterium tuberculosis infection life long?","volume":"367","author":"Behr","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.drup.2024.101156_bib74","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/jac\/dkab505","article-title":"Delamanid or pretomanid? A Solomonic judgement!","volume":"77","author":"Mudde","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.drup.2024.101156_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jac\/dkx351","article-title":"Metronidazole: an update on metabolism, structure\u2013cytotoxicity and resistance mechanisms","volume":"73","author":"Dingsdag","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.drup.2024.101156_bib76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2471\/BLT.19.241349","article-title":"Measuring antibiotic availability and use in 20 low- and middle-income countries","volume":"98","author":"Knowles","year":"2020","journal-title":"Bull. World Health Organ"},{"key":"10.1016\/j.drup.2024.101156_bib77","series-title":"Mechanism of Resistance in Metronidazole BT - Antimicrobial Drug Resistance: Mechanisms of Drug Resistance","first-page":"223","author":"Dhand","year":"2009"},{"issue":"2","key":"10.1016\/j.drup.2024.101156_bib78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jtbi.2004.11.020","article-title":"Diversity in times of adversity: probabilistic strategies in microbial survival games","volume":"234","author":"Wolf","year":"2005","journal-title":"J. Theor. Biol."},{"issue":"20","key":"10.1016\/j.drup.2024.101156_bib79","doi-asserted-by":"crossref","first-page":"13929","DOI":"10.1074\/jbc.R113.472274","article-title":"Programmed heterogeneity: epigenetic mechanisms in bacteria","volume":"288","author":"Casadesus","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2024.101156_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/srep15443","article-title":"Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations","volume":"5","author":"Abdallah","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.drup.2024.101156_bib81","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5588\/ijtld.18.0417","article-title":"Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing","volume":"23","author":"Ismail","year":"2019","journal-title":"Int J. Tube Lung Dis. J. Int Union Tube Lung Dis."},{"key":"10.1016\/j.drup.2024.101156_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1100488","article-title":"Clofazimine for the treatment of tuberculosis","volume":"14","author":"Stadler","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.drup.2024.101156_bib83","first-page":"106","article-title":"Technical report on critical concentrations for TB drug susceptibility testing of medicines used in the treatment of drug-resistant TB. Who","author":"World Health Organization (WHO)","year":"2018","journal-title":"Publ. Online"},{"issue":"18","key":"10.1016\/j.drup.2024.101156_bib84","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1073\/pnas.1907631116","article-title":"Phase variation in Mycobacterium tuberculosis glpK produces transiently heritable drug tolerance","volume":"116","author":"Safi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.drup.2024.101156_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00663-19","article-title":"Common variants in the glycerol kinase gene reduce tuberculosis drug efficacy","volume":"10","author":"Bellerose","year":"2019","journal-title":"MBio"},{"issue":"12","key":"10.1016\/j.drup.2024.101156_bib86","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species","volume":"286","author":"Yano","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.drup.2024.101156_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab021","article-title":"Cofactor F420: an expanded view of its distribution, biosynthesis and roles in bacteria and archaea","volume":"45","author":"Grinter","year":"2021","journal-title":"FEMS Microbiol Rev."},{"issue":"23","key":"10.1016\/j.drup.2024.101156_bib88","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1128\/AEM.02500-16","article-title":"The Redox Cofactor F(420) protects mycobacteria from diverse antimicrobial compounds and mediates a reductive detoxification system","volume":"82","author":"Jirapanjawat","year":"2016","journal-title":"Appl. Environ. Microbiol"},{"issue":"7","key":"10.1016\/j.drup.2024.101156_bib89","article-title":"Collateral sensitivity: An evolutionary trade-off between antibiotic resistance mechanisms, attractive for dealing with drug-resistance crisis","volume":"6","author":"Yekani","year":"2023","journal-title":"Heal Sci. Rep."},{"key":"10.1016\/j.drup.2024.101156_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100959","article-title":"Pyrazinamide-resistant tuberculosis obscured from common targeted molecular diagnostics","volume":"68","author":"Modlin","year":"2023","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2024.101156_bib91","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1745-6215-15-434","article-title":"The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis","volume":"15","author":"Hillery","year":"2014","journal-title":"Trials"},{"issue":"9)","key":"10.1016\/j.drup.2024.101156_bib92","first-page":"1","article-title":"Drivers and sites of diversity in the DNA adenine methylomes of 93 Mycobacterium tuberculosis complex clinical isolates","volume":"9","author":"Samuel","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.drup.2024.101156_bib93","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13059-015-0849-0","article-title":"Circlator: automated circularization of genome assemblies using long sequencing reads","volume":"16","author":"Hunt","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2024.101156_bib94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2105-15-180","article-title":"PBHoney: identifying genomic variants via long-read discordance and interrupted mapping","volume":"15","author":"English","year":"2014","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.drup.2024.101156_bib95","article-title":"MUMmer4: a fast and versatile genome alignment system","volume":"14","author":"Mar\u00e7ais","year":"2018"},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib96","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-13-238","article-title":"Mapping single molecule sequencing reads using Basic Local Alignment with Successive Refinement (BLASR): theory and application","volume":"13","author":"Chaisson","year":"2012","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.drup.2024.101156_bib97","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.drup.2024.101156_bib98","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1038\/s41467-021-26248-1","article-title":"Population structure, biogeography and transmissibility of Mycobacterium tuberculosis","volume":"12","author":"Freschi","year":"2021","journal-title":"Nat. Commun."},{"issue":"May 2015","key":"10.1016\/j.drup.2024.101156_bib99","article-title":"Reconstruction and topological characterization of the sigma factor regulatory network of Mycobacterium tuberculosis","volume":"7","author":"Chauhan","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2024.101156_bib100","unstructured":"Elghraoui A., Valafar F. MVP: Detection of motif-making and -breaking mutations. arXiv. Published online 2022. doi:10.48550\/ARXIV.2210.09842."},{"issue":"SUPPL. 1","key":"10.1016\/j.drup.2024.101156_bib101","first-page":"2010","article-title":"The sequence read archive","volume":"39","author":"Leinonen","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.drup.2024.101156_bib102","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/bioinformatics\/btx063","article-title":"Phyx: phylogenetic tools for unix","volume":"33","author":"Brown","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drup.2024.101156_bib103","series-title":"Microb genomics","article-title":"Exact mapping of Illumina blind spots in the Mycobacterium tuberculosis genome reveals platform-wide and workflow-specific biases","author":"Modlin","year":"2021"},{"issue":"9","key":"10.1016\/j.drup.2024.101156_bib104","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btu033","article-title":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies","volume":"30","author":"Stamatakis","year":"2014","journal-title":"Bioinformatics"},{"issue":"W1","key":"10.1016\/j.drup.2024.101156_bib105","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw290","article-title":"Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees","volume":"44","author":"Letunic","year":"2016","journal-title":"Nucleic Acids Res"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764624001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T20:26:24Z","timestamp":1731097584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764624001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":105,"alternative-id":["S1368764624001146"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2024.101156","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2024.101156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101156"}}